Results 71 to 80 of about 1,151 (123)
Etiopatogenia de las prionopatías una revisión sistemática [PDF]
, 2016 Hace ya casi un siglo desde que Creutzfeldt y Jakob definieran por primera vez la enfermedad que lleva su nombre y sólo 20 años desde que Prusiner descubriera el pilar de su etiopatogenia; y es este último evento el que ha iniciado un paradigma en el ...
Martínez Martín, Patricia +1 more
core
Transmissible amyloid protein: evidence from iatrogenic CJD [PDF]
, 2018 Hu, Mo, Robertson, Neil P.
core +2 more sources
Vascular Neurology Considerations for Antiamyloid Immunotherapy: A Science Advisory From the American Heart Association [PDF]
Antibodies directed at the amyloid-β peptide offer the prospect of disease-modifying therapy for early-stage Alzheimer disease but also carry the risk of brain edema or bleeding events, collectively designated amyloid-related imaging abnormalities ...
Aparicio, Hugo J +8 more
core +1 more source
Stroke research priorities for the next decade - A supplement statement on intracranial haemorrhage [PDF]
, 2007 Al-Shahi, R. +9 more
core +2 more sources
Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone [PDF]
Alzheimer’s disease (AD) is characterized pathologically by amyloid-beta (Aβ) deposition in brain parenchyma and blood vessels (as cerebral amyloid angiopathy (CAA)) and by neurofibrillary tangles of hyperphosphorylated tau.
Banerjee, G +9 more
core
CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysis [PDF]
Introduction: There are limited data regarding cerebrospinal fluid (CSF) and plasma biomarkers among patients with Cerebral Amyloid Angiopathy (CAA). We sought to investigate the levels of four biomarkers [β-amyloids (Aβ42 and Aβ40), total tau (tau) and
Alexandrov, Andrei V +19 more
core